Cargando…

Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges

BACKGROUND: Workplace genetic and/or genomic testing (wGT) is one of many options that employers can offer within the scope of voluntary workplace wellness programs, though we know little about how many employers are offering this benefit, or what kinds of testing are included. METHODS: Our landscap...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohn, Betty, Ryan, Kerry A., Hendy, Katherine, Callahan, Katherine, Roberts, J. Scott, Spector‐Bagdady, Kayte, Mathews, Debra J. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655502/
https://www.ncbi.nlm.nih.gov/pubmed/37592452
http://dx.doi.org/10.1002/mgg3.2245
_version_ 1785136839056687104
author Cohn, Betty
Ryan, Kerry A.
Hendy, Katherine
Callahan, Katherine
Roberts, J. Scott
Spector‐Bagdady, Kayte
Mathews, Debra J. H.
author_facet Cohn, Betty
Ryan, Kerry A.
Hendy, Katherine
Callahan, Katherine
Roberts, J. Scott
Spector‐Bagdady, Kayte
Mathews, Debra J. H.
author_sort Cohn, Betty
collection PubMed
description BACKGROUND: Workplace genetic and/or genomic testing (wGT) is one of many options that employers can offer within the scope of voluntary workplace wellness programs, though we know little about how many employers are offering this benefit, or what kinds of testing are included. METHODS: Our landscaping review sought to discover the prevalence and distribution of wGT within voluntary wellness programs among U.S. companies using three approaches: (1) analysis of publicly available information; (2) national surveys; and (3) interviews with company representatives. RESULTS: In total, 50/420 (11.9%) companies we investigated had publicly available data suggesting that they offer wGT to their employees. Survey data weighted to be representative of the type and distribution of U.S. companies suggest that ~1% of U.S. companies offer wGT to their employees. CONCLUSION: Our research found little evidence of broad uptake of wGT among U.S. companies, though information gathering was challenging.
format Online
Article
Text
id pubmed-10655502
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-106555022023-08-17 Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges Cohn, Betty Ryan, Kerry A. Hendy, Katherine Callahan, Katherine Roberts, J. Scott Spector‐Bagdady, Kayte Mathews, Debra J. H. Mol Genet Genomic Med Original Articles BACKGROUND: Workplace genetic and/or genomic testing (wGT) is one of many options that employers can offer within the scope of voluntary workplace wellness programs, though we know little about how many employers are offering this benefit, or what kinds of testing are included. METHODS: Our landscaping review sought to discover the prevalence and distribution of wGT within voluntary wellness programs among U.S. companies using three approaches: (1) analysis of publicly available information; (2) national surveys; and (3) interviews with company representatives. RESULTS: In total, 50/420 (11.9%) companies we investigated had publicly available data suggesting that they offer wGT to their employees. Survey data weighted to be representative of the type and distribution of U.S. companies suggest that ~1% of U.S. companies offer wGT to their employees. CONCLUSION: Our research found little evidence of broad uptake of wGT among U.S. companies, though information gathering was challenging. John Wiley and Sons Inc. 2023-08-17 /pmc/articles/PMC10655502/ /pubmed/37592452 http://dx.doi.org/10.1002/mgg3.2245 Text en © 2023 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Cohn, Betty
Ryan, Kerry A.
Hendy, Katherine
Callahan, Katherine
Roberts, J. Scott
Spector‐Bagdady, Kayte
Mathews, Debra J. H.
Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges
title Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges
title_full Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges
title_fullStr Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges
title_full_unstemmed Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges
title_short Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges
title_sort genomic testing in voluntary workplace wellness programs in the us: evidence and challenges
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655502/
https://www.ncbi.nlm.nih.gov/pubmed/37592452
http://dx.doi.org/10.1002/mgg3.2245
work_keys_str_mv AT cohnbetty genomictestinginvoluntaryworkplacewellnessprogramsintheusevidenceandchallenges
AT ryankerrya genomictestinginvoluntaryworkplacewellnessprogramsintheusevidenceandchallenges
AT hendykatherine genomictestinginvoluntaryworkplacewellnessprogramsintheusevidenceandchallenges
AT callahankatherine genomictestinginvoluntaryworkplacewellnessprogramsintheusevidenceandchallenges
AT robertsjscott genomictestinginvoluntaryworkplacewellnessprogramsintheusevidenceandchallenges
AT spectorbagdadykayte genomictestinginvoluntaryworkplacewellnessprogramsintheusevidenceandchallenges
AT mathewsdebrajh genomictestinginvoluntaryworkplacewellnessprogramsintheusevidenceandchallenges
AT genomictestinginvoluntaryworkplacewellnessprogramsintheusevidenceandchallenges